Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimization of tumor xenograft dissociation for the profiling of cell surface markers and nutrient transporters.
Petit V, Massonnet G, Maciorowski Z, Touhami J, Thuleau A, Némati F, Laval J, Château-Joubert S, Servely JL, Vallerand D, Fontaine JJ, Taylor N, Battini JL, Sitbon M, Decaudin D. Petit V, et al. Among authors: decaudin d. Lab Invest. 2013 May;93(5):611-21. doi: 10.1038/labinvest.2013.44. Epub 2013 Mar 4. Lab Invest. 2013. PMID: 23459372 Free article.
The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers.
Passeri T, Gutman T, Hamza A, Adle-Biassette H, Girard E, Beaurepere R, Tariq Z, Mariani O, Dahmani A, Bourneix C, Abbritti R, Driouch K, Bohec M, Servant N, Baulande S, Decaudin D, Guichard JP, Calugaru V, Feuvret L, Guinebretière JM, Champion L, Bièche I, Froelich S, Mammar H, Masliah-Planchon J. Passeri T, et al. Among authors: decaudin d. J Neurosurg. 2023 Apr 7;139(5):1270-1280. doi: 10.3171/2023.1.JNS222180. Print 2023 Nov 1. J Neurosurg. 2023. PMID: 37029667
Conjunctival low-grade non-Hodgkin's lymphoma: a large single-center study of initial characteristics, natural history and prognostic factors.
Meunier J, Lumbroso-Le Rouïc L, Dendale R, Vincent-Salomon A, Asselain B, Arnaud P, Némati F, Fourquet A, Desjardins L, Plancher C, Levy C, Chaoui D, Validire P, Decaudin D. Meunier J, et al. Among authors: decaudin d. Leuk Lymphoma. 2006 Jul;47(7):1295-305. doi: 10.1080/10428190500518966. Leuk Lymphoma. 2006. PMID: 16923560
In vivo tumor targeting by the B-subunit of shiga toxin.
Viel T, Dransart E, Nemati F, Henry E, Thézé B, Decaudin D, Lewandowski D, Boisgard R, Johannes L, Tavitian B. Viel T, et al. Among authors: decaudin d. Mol Imaging. 2008 Nov-Dec;7(6):239-47. Mol Imaging. 2008. PMID: 19123994
Preclinical assessment of cisplatin-based therapy versus docetaxel-based therapy on a panel of human non-small-cell lung cancer xenografts.
Némati F, Bras-Gonçalves R, Fontaine JJ, de Pinieux G, De Cremoux P, Chapelier A, Daniel C, Laurent-Puig P, Livartowski A, Judde JG, Bordier V, Poupon MF, Decaudin D. Némati F, et al. Among authors: decaudin d. Anticancer Drugs. 2009 Nov;20(10):932-40. doi: 10.1097/CAD.0b013e32833009cc. Anticancer Drugs. 2009. PMID: 19741504
168 results